
“The quality and coverage of B2B contact database are very impressive...”
Mark J.
`
+4
Geneoscopy Inc. is a life sciences company focused on developing diagnostic tests for gastrointestinal health. Leveraging its proprietary, patented stool-derived eukaryotic RNA (seRNA) biomarker platform, Geneoscopys mission is to empower patients and providers to transform gastrointestinal health through innovative diagnostics. The companys FDA-approved ColoSenseTM test uses a proprietary RNA-based platform to screen for colorectal cancer and advanced adenomas for average-risk individuals over the age of 45. In partnership with leading universities and biopharmaceutical companies, Geneoscopy is also developing diagnostic tests for treatment selection and therapy monitoring in other GI disease areas. For more information, visit www.geneoscopy.com and follow the company...
Life sciences,noninvasive diagnostic screening,colorectal cancer screening,gi health,gi disease companion diagnostics,serna,rna biomarkers,precision medicine partnerships,and ibd
Geneoscopy operates in the Biotechnology research industry.
Geneoscopy's revenue is 11m - 100m
Geneoscopy has 51 - 200 employees.
Get Started with the Free Forever plan! No credit card needed. Enjoy up to 10,000 free email credits per month at no cost.
Start Prospecting from Clodura.AI's database of 600M+ verified B2B contacts and 120M+ direct dials along with 18M+ companies' org charts.
Unlock the prospect's contact details, including verified email, direct dials, add them to cadence, and close more deals.